Unither Revenue and Competitors

Paris, France

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Unither's estimated annual revenue is currently $298.5M per year.(i)
  • Unither's estimated revenue per employee is $201,000

Employee Data

  • Unither has 1485 Employees.(i)
  • Unither grew their employee count by 7% last year.

Unither's People

NameTitleEmail/Phone
1
Head Consolidation, Reporting and Accounting standardsReveal Email/Phone
2
Director Supply ChainReveal Email/Phone
3
Commercial Director North AmericaReveal Email/Phone
4
Site DirectorReveal Email/Phone
5
CFO & IT DirectorReveal Email/Phone
6
Logistics ManagerReveal Email/Phone
7
QC Lab ManagerReveal Email/Phone
8
Non-Sterile Production Manager (Manufacturing/Packaging)Reveal Email/Phone
9
Senior Product Development ManagerReveal Email/Phone
10
Middleware Manager & Data PartnerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$45.6M2270%N/AN/A
#2
$19.3M965%N/AN/A
#3
$36.2M1805%N/AN/A
#4
$34M16933%N/AN/A
#5
$173.7M86420%N/AN/A
#6
$45M2242%N/AN/A
#7
$48.2M2406%N/AN/A
#8
$22.1M1108%N/AN/A
#9
$22.1M110-13%N/AN/A
#10
$27.5M1371%N/AN/A
Add Company

What Is Unither?

Unither Pharmaceuticals, with seven manufacturing plants (France, USA, Brazil and China) four commercial offices and one R&D platform, is the worldwide leader in sterile unit-doses contract manufacturing. Unither Pharmaceuticals manufactures several product lines, using highly innovative and competitive niche technologies such as: Liquid Stick-Pack, Sterile unit-dose (Blow Fill & Seal Technology), Powder Stick-Pack, Oral liquids and Suspensions, Suppositories and Pessaries, Effervescent tablets, Orodispersible Solutions and Extended Release formulations. Our products are sold in more than 100 countries for an annual turnover of 320 million euros. Our vision is to make affordable and user-friendly products that everyone in the world can use to improve their lives. Our mission is to deliver innovative, competitive and sustainable solutions to our customers: pharmaceutical companies. Our promise is to consider patients' needs in order to make successful products for our pharmaceutical clients. Unither Pharmaceuticals, avec ses sept usines de fabrication (France, USA, Brésil et Chine) ses quatre bureaux commerciaux et sa plateforme de R&D, est le leader mondial de la sous-traitance d'unidoses stériles. Unither Pharmaceuticals fabrique plusieurs gammes de produits, à l'aide de technologies de niche très novatrices et concurrentielles, telles que : Unisticks® liquides, Unidoses stériles (technologie Blow Fill & Seal), Unisticks® poudre, Liquides, Suspensions et Solutions buvables, Suppositoires et Ovules, Comprimés effervescents, Formes orodispersibles et Formulations à libération modifiée. Ces produits sont vendus dans plus de 100 pays pour un chiffre d'affaires annuel de 320 millions d'euros. Notre mission est d'offrir des solutions innovantes, compétitives et durables à nos clients : sociétés pharmaceutiques. Notre promesse est de prendre en compte les besoins du patient pour aider nos clients à faire de leurs produits un succès sur le marché.

keywords:N/A

N/A

Total Funding

1485

Number of Employees

$298.5M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Unither News

2022-04-20 - Cromolyn Sodium Market Size, Share, Growth 2022-2030 ...

Unither Pharmaceuticals; Yongguang Pharmaceutical; Farmak; Santen; Sanofi; Evolan; Shandong Furuida Biological; Shanghai Sine Pharmaceutical...

2022-04-20 - Foamed Packaging Market Size, Outlook And Forecast ...

Romaco Pharmatechnik GmbH, Amcor Limited, Unither Pharmaceuticals, Sanner GmbH, Oracle Packaging, Tower Laboratories, Ltd., Amerilab...

2022-04-17 - Blow Fill Seal Equipment Market Size And Forecast ...

... Ritedose Corporation, Recipharm, Pharmapack, Curida, Weiler Engineering, Unicep Packaging, Unither Pharmaceuticals and Lyondellbasell.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$688.9M15336%N/A
#2
$288.3M15514%N/A
#3
$1.7M15897%N/A
#4
$650.5M16195%N/A
#5
$301.5M162215%$703.9M